SELLAS Life Sciences to Present at the 2021 Cantor Virtual Global Healthcare Conference on September 28th
NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS" or the “Company”), a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for a broad range of indications, today announced that Angelos Stergiou, MD, ScD. h.c., President and Chief Executive Officer of SELLAS, will present at the 2021 Cantor Global Healthcare Conference to be held virtually on Tuesday, September 28, 2021, at 4:00 p.m. ET.
For more information about the conference, or to schedule a one-on-one meeting with SELLAS management, please contact your Cantor representative directly, or send an email to Cantor at email@example.com or KCSA Strategic Communications at SELLAS@kcsa.com.
About SELLAS Life Sciences Group, Inc.
For more information on SELLAS, please visit www.sellaslifesciences.com.
For more information, please contact:
Getting to the Relevant (meta) Data
IoT Evolution Expo #TECHSUPERSHOW Expo Hall Open
Grand Opening Networking Reception in Expo Hall